Meridian Wealth Advisors, LLC Abbott Laboratories Transaction History

Meridian Wealth Advisors, LLC

$536 Million
Q3 2024

A detailed history of Meridian Wealth Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Meridian Wealth Advisors, LLC holds 7,654 shares of ABT stock, worth $901,335. This represents 0.16% of its overall portfolio holdings.

Number of Shares

7,654

Previous 7,615 0.51%

Holding current value

$901,335

Previous $791,000 10.24%

% of portfolio

0.16%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$100.07 - $118.13 $3,902 - $4,607	39 Added 0.51%	7,654 $872,000
Q2 2024 Aug 02, 2024	BUY	$100.73 - $112.44 $4,734 - $5,284	47 Added 0.62%	7,615 $791,000
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $304,355 - $339,115	-3,020 Reduced 28.52%	7,568 $825,000
Q4 2022 Jan 23, 2023	SELL	$95.06 - $111.52 $5,893 - $6,914	-62 Reduced 0.58%	10,588 $0
Q3 2022 Oct 19, 2022	SELL	$96.76 - $112.03 $22,254 - $25,766	-230 Reduced 2.11%	10,650 $1.03 Million
Q2 2022 Jul 26, 2022	BUY	$102.07 - $123.37 $124,321 - $150,264	1,218 Added 12.61%	10,880 $1.18 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $118,694 - $144,740	1,041 Added 12.08%	9,662 $1.14 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $7,856 - $9,619	68 Added 0.8%	8,621 $1.21 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $148,952 - $175,338	1,408 Added 19.71%	8,553 $992,000
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $27,754 - $32,698	-255 Reduced 3.45%	7,145 $856,000
Q4 2020 May 07, 2021	SELL	$105.0 - $114.42 $27,300 - $29,749	-260 Reduced 3.39%	7,400 $810,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $24,675 - $26,888	235 Added 3.16%	7,660 $665,000
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $23,826 - $28,935	260 Added 3.63%	7,425 $808,000
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $11,179 - $14,308	146 Added 2.08%	7,165 $655,000
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $17,652 - $25,812	-281 Reduced 3.85%	7,019 $554,000
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $120,141 - $130,270	1,468 Added 25.17%	7,300 $611,000
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $18,220 - $21,250	250 Added 4.48%	5,832 $498,000
Q1 2019 May 07, 2019	SELL	$66.22 - $80.06 $16,223 - $19,614	-245 Reduced 4.2%	5,582 $446,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $382,018 - $432,771	5,827 New	5,827 $421,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Advisors, LLC with notifications on news.

Account

Meridian Wealth Advisors, LLC Abbott Laboratories Transaction History